Ticker
RLYBCompany Name
RALLYBIO CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Shareholders Equity | Net Income Common Stock | Return on Equity |
---|---|---|---|
6/30/2025 | $ 45.96M | $ -41.65M | -90.62% |
3/31/2025 | $ 54.07M | $ -48.19M | -89.11% |
12/31/2024 | $ 61.65M | $ -57.77M | -93.71% |
9/30/2024 | $ 70.82M | $ -66.97M | -94.57% |
6/30/2024 | $ 80.02M | $ -73.88M | -92.33% |
3/31/2024 | $ 89.16M | $ -76.28M | -85.55% |
12/31/2023 | $ 106.18M | $ -74.56M | -70.22% |
9/30/2023 | $ 123.58M | $ -70.53M | -57.07% |
6/30/2023 | $ 139.26M | $ -70.52M | -50.64% |
3/31/2023 | $ 155.2M | $ -69.47M | -44.77% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Equity
(=) ROE
ROE for RALLYBIO CORP is calculated as follows: Net Inc. Cmn. [ $ -26.45M ] / Equity [ $ -46.02M ]
(=) ROE [ 0% ]
Minimum
Sep 30, 2024
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.13K |
---|---|
min | -66.24% |
max | 73.25% |
average | 1.63% |
median | 6.53% |
std | 22.52% |